genpact - G

G

Close Chg Chg %
50.02 0.38 0.76%

Closed Market

50.40

+0.38 (0.76%)

Volume: 1.25M

Last Updated:

Mar 31, 2025, 3:59 PM EDT

Company Overview: genpact - G

G Key Data

Open

$49.72

Day Range

48.96 - 50.66

52 Week Range

30.25 - 56.76

Market Cap

$8.78B

Shares Outstanding

175.67M

Public Float

160.94M

Beta

1.17

Rev. Per Employee

N/A

P/E Ratio

17.56

EPS

$2.88

Yield

122.00%

Dividend

$0.17

EX-DIVIDEND DATE

Mar 11, 2025

SHORT INTEREST

N/A

AVERAGE VOLUME

1.42M

 

G Performance

1 Week
 
0.00%
 
1 Month
 
-6.05%
 
3 Months
 
16.41%
 
1 Year
 
51.75%
 
5 Years
 
90.84%
 

G Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 12
Full Ratings ➔

About genpact - G

Genpact Ltd. engages in the business process management, outsourcing, shared services and information outsourcing. The company operates through the following segments: Banking, Capital Markets and Insurance (BCMI), Consumer Goods, Retail, Life Sciences, and Healthcare (CGRLH) and High Tech, Manufacturing, and Services (HMS). The BCMI segment provides application processing, collections and customer services, equipment and auto loan servicing, mortgage origination and servicing, risk management and compliance services, reporting and monitoring services, wealth management operations support, end-to-end information technology services, application development and maintenance, managed services, financial crimes support, and consulting. The CGRLH segment offers supply chain management, pricing and trade promotion management, order management, digital commerce, customer experience, and risk management. The HMS segment involves industry-specific solutions for the Industrial Internet of Things (IIoT), user experience, order and supply chain management, data engineering, digital content management, and risk management. The company was founded in 1997 by Pramod Bhasin and is headquartered in Hamilton, Bermuda.

G At a Glance

Genpact Ltd.
Canon's Court
Hamilton, Hamilton HM 12
Phone 1-441-298-3300 Revenue 4.76B
Industry Miscellaneous Commercial Services Net Income 513.67M
Sector Commercial Services 2024 Sales Growth 6.464%
Fiscal Year-end 12 / 2025 Employees 140,000
View SEC Filings

G Valuation

P/E Current 17.564
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 15.087
Price to Sales Ratio 1.626
Price to Book Ratio 3.139
Price to Cash Flow Ratio 12.593
Enterprise Value to EBITDA 11.034
Enterprise Value to Sales 1.789
Total Debt to Enterprise Value 0.17

G Efficiency

Revenue/Employee 34,035.279
Income Per Employee 3,669.071
Receivables Turnover 3.86
Total Asset Turnover 0.973

G Liquidity

Current Ratio 2.158
Quick Ratio 2.158
Cash Ratio 0.697

G Profitability

Gross Margin 34.725
Operating Margin 14.408
Pretax Margin 14.204
Net Margin 10.78
Return on Assets 10.491
Return on Equity 22.15
Return on Total Capital 13.395
Return on Invested Capital 14.686

G Capital Structure

Total Debt to Total Equity 60.474
Total Debt to Total Capital 37.685
Total Debt to Total Assets 28.976
Long-Term Debt to Equity 56.815
Long-Term Debt to Total Capital 35.405
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Genpact - G

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
4.02B 4.37B 4.48B 4.76B
Sales Growth
+8.53% +8.62% +2.47% +6.46%
Cost of Goods Sold (COGS) incl D&A
2.66B 2.87B 2.94B 3.11B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
151.44M 116.74M 92.91M 85.89M
Depreciation
68.00M 59.31M 52.87M 57.35M
Amortization of Intangibles
83.44M 57.44M 40.03M 28.54M
COGS Growth
+8.94% +7.85% +2.53% +5.74%
Gross Income
1.36B 1.50B 1.53B 1.65B
Gross Income Growth
+7.72% +10.13% +2.36% +7.85%
Gross Profit Margin
+33.85% +34.32% +34.28% +34.73%
2021 2022 2023 2024 5-year trend
SG&A Expense
867.55M 937.24M 913.63M 968.09M
Research & Development
- - - -
-
Other SG&A
867.55M 937.24M 913.63M 968.09M
SGA Growth
+10.38% +8.03% -2.52% +5.96%
Other Operating Expense
- - - -
-
Unusual Expense
(10.77M) 83.31M (18.45M) 10.32M
EBIT after Unusual Expense
504.23M 478.27M 639.06M 676.22M
Non Operating Income/Expense
29.32M 44.48M 37.81M 81.46M
Non-Operating Interest Income
6.88M 5.90M 18.37M 32.29M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
50.42M 57.52M 74.64M 80.86M
Interest Expense Growth
-2.02% +14.08% +29.77% +8.33%
Gross Interest Expense
50.42M 57.52M 74.64M 80.86M
Interest Capitalized
- - - -
-
Pretax Income
483.13M 465.24M 602.22M 676.82M
Pretax Income Growth
+20.64% -3.70% +29.44% +12.39%
Pretax Margin
+12.02% +10.65% +13.46% +14.20%
Income Tax
113.68M 111.83M (29.03M) 163.15M
Income Tax - Current - Domestic
40.14M 22.11M 27.78M 48.24M
Income Tax - Current - Foreign
82.80M 118.88M 101.12M 78.30M
Income Tax - Deferred - Domestic
(5.81M) (12.39M) (154.28M) 18.77M
Income Tax - Deferred - Foreign
(3.46M) (16.76M) (3.65M) 17.84M
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
369.45M 353.40M 631.25M 513.67M
Minority Interest Expense
- - - -
-
Net Income
369.45M 353.40M 631.25M 513.67M
Net Income Growth
+19.84% -4.34% +78.62% -18.63%
Net Margin Growth
+9.19% +8.09% +14.10% +10.78%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
369.45M 353.40M 631.25M 513.67M
Preferred Dividends
- - - -
-
Net Income Available to Common
369.45M 353.40M 631.25M 513.67M
EPS (Basic)
1.9672 1.9188 3.4619 2.8795
EPS (Basic) Growth
+21.50% -2.46% +80.42% -16.82%
Basic Shares Outstanding
187.80M 184.18M 182.35M 178.39M
EPS (Diluted)
1.9146 1.8789 3.4096 2.8468
EPS (Diluted) Growth
+21.59% -1.86% +81.47% -16.51%
Diluted Shares Outstanding
192.96M 188.09M 185.14M 180.44M
EBITDA
644.89M 678.32M 713.51M 772.43M
EBITDA Growth
+1.13% +5.18% +5.19% +8.26%
EBITDA Margin
+16.04% +15.53% +15.94% +16.21%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 50.222
Number of Ratings 12 Current Quarters Estimate 0.864
FY Report Date 06 / 2025 Current Year's Estimate 3.548
Last Quarter’s Earnings 0.79 Median PE on CY Estimate N/A
Year Ago Earnings 3.28 Next Fiscal Year Estimate 3.909
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 9 9 10 10
Mean Estimate 0.86 0.92 3.55 3.91
High Estimates 0.89 0.93 3.58 4.03
Low Estimate 0.85 0.90 3.52 3.80
Coefficient of Variance 1.43 1.19 0.51 1.61

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 5 5 3
OVERWEIGHT 0 0 0
HOLD 6 6 9
UNDERWEIGHT 1 1 0
SELL 0 0 0
MEAN Overweight Overweight Hold

Insider Actions for Genpact - G

Date Name Shares Transaction Value
Mar 17, 2025 Balkrishan Kalra President and CEO; Director 42,800 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Mar 17, 2025 Balkrishan Kalra President and CEO; Director 310,246 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $48.89 per share 15,167,926.94
Mar 17, 2025 Balkrishan Kalra President and CEO; Director 323,846 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $27.65 per share 8,954,341.90
Mar 14, 2025 Donald J. Klunk Chief Accounting Officer 11,351 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 14, 2025 Sameer Dewan Senior Vice President 109,226 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 14, 2025 Riju Vashisht Senior Vice President 147,649 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 14, 2025 Anil Nanduru Senior Vice President 117,571 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 14, 2025 Michael Weiner Chief Financial Officer 161,222 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 14, 2025 Heather D. White SVP & Chief Legal Officer 51,578 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 14, 2025 Piyush Mehta Senior Vice President and CHRO 161,498 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 21, 2025 N. V. Tyagarajan Director 604,631 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $54.87 per share 33,176,102.97
May 7, 2024 Brian Stevens Director 25,273 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 7, 2024 Carol Lindstrom Director 26,820 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 7, 2024 Tamara Simpkins Franklin Director 20,161 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 7, 2024 Ajay K. Agrawal Director 34,147 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 7, 2024 Mark A. Verdi Director 60,180 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 7, 2024 Laura C. Conigliaro Director 67,991 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 7, 2024 Cecelia G. Morken Director 52,935 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 7, 2024 James C. Madden Director 55,486 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00

Genpact in the News